Version 1
: Received: 25 September 2023 / Approved: 26 September 2023 / Online: 28 September 2023 (13:01:45 CEST)
Version 2
: Received: 13 March 2024 / Approved: 14 March 2024 / Online: 14 March 2024 (11:12:37 CET)
How to cite:
Finding, E.J.T.; Faulkner, A.; Wheeler-Jones, C. Equine endothelial Cells Show Pro-Angiogenic Behaviours in Response to FGF2 but not VEGF-A. Preprints2023, 2023092006. https://doi.org/10.20944/preprints202309.2006.v1
Finding, E.J.T.; Faulkner, A.; Wheeler-Jones, C. Equine endothelial Cells Show Pro-Angiogenic Behaviours in Response to FGF2 but not VEGF-A. Preprints 2023, 2023092006. https://doi.org/10.20944/preprints202309.2006.v1
Finding, E.J.T.; Faulkner, A.; Wheeler-Jones, C. Equine endothelial Cells Show Pro-Angiogenic Behaviours in Response to FGF2 but not VEGF-A. Preprints2023, 2023092006. https://doi.org/10.20944/preprints202309.2006.v1
APA Style
Finding, E.J.T., Faulkner, A., & Wheeler-Jones, C. (2023). Equine endothelial Cells Show Pro-Angiogenic Behaviours in Response to FGF2 but not VEGF-A. Preprints. https://doi.org/10.20944/preprints202309.2006.v1
Chicago/Turabian Style
Finding, E.J.T., Ashton Faulkner and Caroline Wheeler-Jones. 2023 "Equine endothelial Cells Show Pro-Angiogenic Behaviours in Response to FGF2 but not VEGF-A" Preprints. https://doi.org/10.20944/preprints202309.2006.v1
Abstract
Understanding the factors which control endothelial cell (EC) function and angiogenesis in the horse is crucial for developing the horse as a disease model but equine ECs remain poorly studied. In this study we have optimised methods for the isolation and culture of equine aortic endothelial cells (EAoECs) and characterised their angiogenic functions in vitro. Mechanical dissociation, followed by magnetic purification using an anti-VE-cadherin antibody, resulted in EC-enriched cultures suitable for further study. Fibroblast growth factor 2 (FGF2) increased EAoEC proliferation rate and stimulated scratch wound closure and tube formation by EAoECs on extracellular matrix. Pharmacological inhibitors of FGFR1 (SU5402) or MEK (PD184352) blocked FGF2-induced ERK1/2 phosphorylation and functional responses, suggesting that these are dependent on FGFR1/MEK-ERK signalling. In marked contrast, VEGF-A had no effect on EAoEC proliferation, migration or tubulogenesis and did not promote ERK1/2 phosphorylation, indicating a lack of sensitivity to this classical pro-angiogenic growth factor. Gene expression analysis showed that, unlike human ECs, FGFR1 is expressed by EAoECs at a much higher level than both VEGFR1 and VEGFR2. These results suggest a predominant role for FGF2 versus VEGF-A in controlling the angiogenic functions of equine ECs. Collectively, our novel data provide a sound basis for studying angiogenic processes in the horse and lay the foundations for comparative studies of EC biology in horses versus humans.
Keywords
equine; endothelial; angiogenesis; comparative
Subject
Biology and Life Sciences, Cell and Developmental Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
